Industry Developments

BMI View: Reforms to improve access to high quality healthcare in Argentina are increasingly being scrutinised in light of the current inequalities in the provision of medical services... 2010-09-08

BMI Core View: Corporate social responsibility (CSR) is an under-appreciated business activity in the pharmaceutical industry. Like all commercial entities, pharmaceutical and medical... 2010-09-03

BMI View: Pfizer is to expand into a promising but risky field of research and development (R&D), following its acquisition of FoldRx Pharmaceuticals. BMI believes that with the... 2010-09-02

BMI View: Despite Chile's relatively small pharmaceutical market in comparison with other Latin American countries, market growth opportunities will continue to attract investors looking... 2010-09-01

BMI View: Due to first-mover advantage, EMS is set to dominate the generic atorvastatin market, while Pfizer's partner Eurofarma awaits regulatory approval.

BMI View: Despite significant regional variations, Latin America's regulatory environment will continue to evolve and become increasingly similar to those of developed pharmaceutical... 2010-08-27

BMI View: Despite the recent US healthcare overhaul increasing access to medical services, President Barack Obama intends to slow the growth rate of the healthcare budget. In light... 2010-08-26

BMI View: Despite government incentives for the US bioweapon countermeasure market segment, biotechnology companies are likely to remain cautious, given the small profit margins and... 2010-08-25

BMI View: Improvements in supply chain technologies in Argentina will contribute to reducing the current high levels of counterfeit medicines. BMI believes the promotion of generic... 2010-08-23

BMI View: Canada's healthcare system is under increasing financial pressure. Healthcare costs are rising because of the country's demographic trends, particularly its ageing-population.... 2010-08-20